Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent of Day One Biopharmaceuticals, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Day One Biopharmaceuticals, Inc. annual and quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Day One Biopharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending 30 Sep 2024 was 0.21.
  • Day One Biopharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2024 was 0.21, unchanged from 2023.
  • Day One Biopharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21, unchanged from 2022.
  • Day One Biopharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21, unchanged from 2021.
Source SEC data
View on sec.gov
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Change (%)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)

Day One Biopharmaceuticals, Inc. Annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent (pure)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 0.21 0 0% 01 Jan 2024 31 Dec 2024 10-K/A 06 Mar 2025 2024 FY
2023 0.21 0 0% 01 Jan 2023 31 Dec 2023 10-K/A 06 Mar 2025 2024 FY
2022 0.21 0 0% 01 Jan 2022 31 Dec 2022 10-K/A 06 Mar 2025 2024 FY
2021 0.21 0 0% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 0.21 0 0% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
2019 0.21 01 Jan 2019 31 Dec 2019 10-K 07 Mar 2022 2021 FY

Day One Biopharmaceuticals, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent (pure)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 0.21 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 0.21 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.